Literature DB >> 20099009

Hydroxyapatite scaffolds processed using a TBA-based freeze-gel casting/polymer sponge technique.

Tae Young Yang1, Jung Min Lee, Seog Young Yoon, Hong Chae Park.   

Abstract

A novel freeze-gel casting/polymer sponge technique has been introduced to fabricate porous hydroxyapatite scaffolds with controlled "designer" pore structures and improved compressive strength for bone tissue engineering applications. Tertiary-butyl alcohol (TBA) was used as a solvent in this work. The merits of each production process, freeze casting, gel casting, and polymer sponge route were characterized by the sintered microstructure and mechanical strength. A reticulated structure with large pore size of 180-360 microm, which formed on burn-out of polyurethane foam, consisted of the strut with highly interconnected, unidirectional, long pore channels (approximately 4.5 microm in dia.) by evaporation of frozen TBA produced in freeze casting together with the dense inner walls with a few, isolated fine pores (<2 microm) by gel casting. The sintered porosity and pore size generally behaved in an opposite manner to the solid loading, i.e., a high solid loading gave low porosity and small pore size, and a thickening of the strut cross section, thus leading to higher compressive strengths.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20099009     DOI: 10.1007/s10856-010-4000-1

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  14 in total

Review 1.  The design of scaffolds for use in tissue engineering. Part I. Traditional factors.

Authors:  S Yang; K F Leong; Z Du; C K Chua
Journal:  Tissue Eng       Date:  2001-12

2.  Preparation of porous hydroxyapatite scaffolds by combination of the gel-casting and polymer sponge methods.

Authors:  Hassna Rehman Ramay; Miqin Zhang
Journal:  Biomaterials       Date:  2003-08       Impact factor: 12.479

3.  Sintering and characterization of HA and TCP bioceramics with control of their strength and phase purity.

Authors:  A Tampieri; G Celotti; F Szontagh; E Landi
Journal:  J Mater Sci Mater Med       Date:  1997-01       Impact factor: 3.896

4.  Fabrication of HA/TCP scaffolds with a graded and porous structure using a camphene-based freeze-casting method.

Authors:  A Macchetta; I G Turner; C R Bowen
Journal:  Acta Biomater       Date:  2008-12-06       Impact factor: 8.947

5.  Bioactive and biocompatible pieces of HA/sol-gel glass mixtures obtained by the gel-casting method.

Authors:  S Padilla; S Sánchez-Salcedo; M Vallet-Regí
Journal:  J Biomed Mater Res A       Date:  2005-10-01       Impact factor: 4.396

6.  Three-dimensional macroporous calcium phosphate bioceramics with nested chitosan sponges for load-bearing bone implants.

Authors:  Yong Zhang; Miqin Zhang
Journal:  J Biomed Mater Res       Date:  2002-07

7.  Surface-active biomaterials.

Authors:  L L Hench; J Wilson
Journal:  Science       Date:  1984-11-09       Impact factor: 47.728

8.  Petal-like apatite formed on the surface of tricalcium phosphate ceramic after soaking in distilled water.

Authors:  F H Lin; C J Liao; K S Chen; J S Su; C P Lin
Journal:  Biomaterials       Date:  2001-11       Impact factor: 12.479

9.  Hydroxyapatite porous scaffold engineered with biological polymer hybrid coating for antibiotic Vancomycin release.

Authors:  Hae-Won Kim; Jonathan C Knowles; Hyoun-Ee Kim
Journal:  J Mater Sci Mater Med       Date:  2005-03       Impact factor: 3.896

10.  Hydroxyapatite implants with designed internal architecture.

Authors:  T M Chu; J W Halloran; S J Hollister; S E Feinberg
Journal:  J Mater Sci Mater Med       Date:  2001-06       Impact factor: 3.896

View more
  2 in total

Review 1.  Calcium Orthophosphate-Based Bioceramics.

Authors:  Sergey V Dorozhkin
Journal:  Materials (Basel)       Date:  2013-09-06       Impact factor: 3.623

2.  Synthesis and Tribological Properties of Bio-Inspired Nacre-Like Composites.

Authors:  Hang Zhang; Shuhai Liu; Huaping Xiao; Xun Zhang
Journal:  Materials (Basel)       Date:  2018-08-30       Impact factor: 3.623

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.